Coya Therapeutics falls after $15 mln IPO
** Shares of biotech company Coya Therapeutics Inc COYA.O
down 9% at $4.55 following initial public offering
** COYA announces IPO of 3.1 mln shares, with warrants to
purchase up to 1.5 mln common shares urn:newsml:reuters.com:*:nBw9sdHlBa
** Each share and warrant is being sold at a combined
offering price of $5, for gross proceeds of $15 mln - COYA
** Co says it intends to use all of net proceeds from
offering to advance its programs in pre-clinical studies into
clinical trials
** The offering is expected to close on Jan. 3, 2023
(Reporting by Arshreet Singh in Bengaluru)
((Arshreet.Singh@thomsonreuters.com))
Recent news on Coya Therapeutics
See all newsCoya Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Coya Therapeutics Q2 net loss widens as R&D costs rise
Coya Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Coya Therapeutics Entered Into Sales Agreement, May Offer And Sell From Time To Time Shares Of Co's Common Stock For Up To $30 Million
Brief: Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation For Coya 302 For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)